Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2014; 20(23): 7442-7451
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7442
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7442
Figure 4 Occludin and zona occludens-1 protein expression after heterotopic intestinal transplantation.
Occludin and zona occludens (ZO)-1 protein expression was significantly lower in group B than in group A (aP < 0.05 vs group B at day 5: 0.2082 ± 0.0582 vs 0.5477 ± 0.0284; aP < 0.05 vs group B at day 7: 0.3415 ± 0.0128 vs 0.6387 ± 0.046). Occludin and ZO-1 protein expression was significantly higher in group C than in group B (aP < 0.05 vs group B at day 7: 0.2674 ± 0.0128 vs 0.1352 ± 0.0142; aP < 0.05 vs group B at day 5: 0.7189 ± 0.0289 vs 0.4556 ± 0.0242). A: Group A (non-rejection); B: Group B (rejection); C: Group C (bone marrow mesenchymal stem cells therapy). β-actin was used as the loading control. Values shown are the mean ± SD.
- Citation: Zhang W, Shen ZY, Song HL, Yang Y, Wu BJ, Fu NN, Liu T. Protective effect of bone marrow mesenchymal stem cells in intestinal barrier permeability after heterotopic intestinal transplantation. World J Gastroenterol 2014; 20(23): 7442-7451
- URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7442.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i23.7442